Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.

Singh, Sonal; Loke, Yoon K; Furberg, Curt D
JAMA : the journal of the American Medical Association; 2007 Sep 12;298(10):1189-95. PMID: 17848653
Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.


Recent reports of serious adverse events with rosiglitazone use have raised questions about whether the evidence of harm justifies its use for treatment of type 2 diabetes.